| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 8,389 | 13,072 | 7,850 | | Selling General and Administrative | 3,341 | 3,418 | 5,461 | | Non Recurring | 3 | 13 | 2 | | Others | 234 | 233 | 174 | | | | Total Operating Expenses | 11,967 | 16,736 | 13,488 | | | | Operating Income or Loss | (11,967) | (16,736) | (13,488) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 135 | 2,085 | 840 | | Earnings Before Interest And Taxes | (11,832) | (14,651) | (12,648) | | Interest Expense | 20 | 16 | 1 | | Income Before Tax | (11,852) | (14,667) | (12,649) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,852) | (14,667) | (12,649) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,852) | (14,667) | (12,649) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,852) | ($14,667) | ($12,649) |
|
0.51% Nasdaq 
0.01 (0.50%) 
Income Statement
